2637 篇
1090 篇
194740 篇
3328 篇
6319 篇
2233 篇
2787 篇
537 篇
29666 篇
9821 篇
3163 篇
759 篇
2304 篇
1321 篇
450 篇
752 篇
1387 篇
2612 篇
2741 篇
4049 篇
全球肝细胞癌治疗市场预测流行病学管道分析(2022-2027年)
Global Hepatocellular Carcinoma Treatment Market Forecast - Epidemiology Pipeline Analysis 2022-2027
Hepatocellular Carcinoma (HCC) is the most common type of primary liver cancer. Hepatocellular carcinoma constitutes more than 90% of the primary tumor of the liver. Hepatocellular carcinoma occurs most often in people with chronic liver diseases, such as cirrhosis caused by hepatitis B or hepatitis C infection, accounting for ~50% of cases.
CHAPTER – 1: HEPATOCELLULAR CARCINOMA OVERVIEW
CHAPTER – 2: HEPATOCELLULAR CARCINOMA EPIDEMIOLOGY & OVERVIEW
CHAPTER - 3: HEPATOCELLULAR CARCINOMA MARKET SIZE & OVERVIEW
CHAPTER – 4: HEPATOCELLULAR CARCINOMA MARKETED DRUGS OVERVIEW
CHAPTER – 5: HEPATOCELLULAR CARCINOMA PIPELINE DRUGS OVERVIEW